PPD, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
PPD, Inc. | PPD - NASDAQ |
$24.00-$27.00 |
$27.00 |
$31.00 | 60 million | 2/6/2020 |
Barclays, JP Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank, Evercore ISI, HSBC, Mizuho Securities
|
Co-Manager(s): Baird, WIlliam Blair, Drexel Hamilton |
Health Care |
Filing(s): Filed 2020-01-09 Terms Added 2020-01-27
|
For IPO Boutique's "scale of 1 to 5" BUY rating on PPD, Inc., and our comprehensive analysis, click "Buy Market Research".
PPD, Inc. Quote & Chart - Click for current quote -
PPD
About PPD, Inc. (adapted from PPD, Inc. prospectus):
They are a leading provider of drug development services to the biopharmaceutical industry, focused on helping their customers bring new medicines to patients around the world.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "PPD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved